Welcome to our dedicated page for IonQ SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ security holder plans to sell 5,000 common shares under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $242,400.00, on the NYSE. The filing notes that there are 354,279,591 common shares outstanding, providing a baseline for the company’s total share count. The 5,000 shares were acquired on 12/22/2025 by exercising stock options for cash on the same date.
The notice also lists prior Rule 10b5-1 activity, showing that 10b5-1 sales for Kathryn Chou included 20,000 common shares sold on 12/11/2025 for gross proceeds of $1,027,980.00. By signing, the seller represents that they are not aware of undisclosed material adverse information about IonQ.
IonQ, Inc.'s President, CEO and director reported a sale of 16,290 shares of common stock on 12/11/2025 at a weighted average price of $50.4865 per share.
The shares were sold to satisfy the reporting person's tax liability arising from the vesting of restricted stock units. After this transaction, the insider directly beneficially owns 1,164,896 shares of IonQ common stock.
IonQ, Inc.'s Chief Business Officer reported selling 19,586 shares of common stock to satisfy tax obligations from vesting restricted stock units (RSUs). The shares were sold at a weighted average price of $50.4865, with transaction prices ranging from $49.09 to $52.00. Following this tax-related sale, the officer beneficially owns 216,457 shares of IonQ common stock directly.
IonQ, Inc. reported an insider share sale by a senior officer. The company’s CAO, CLO and Secretary disposed of 4,132 shares of common stock on 12/11/2025 at a weighted average price of $50.4865 in a transaction reported under code F.
The explanation states these shares were sold to satisfy the reporting person’s tax liability arising from the vesting of restricted stock units. Following this tax-related sale, the officer directly beneficially owns 110,322 shares of IonQ common stock.
IonQ, Inc. (IONQ) Chief Financial and Operating Officer reported a routine share sale tied to equity compensation. On December 11, 2025, the officer disposed of 12,553 shares of common stock in a transaction coded "F," meaning the shares were sold to cover tax obligations from the vesting of restricted stock units (RSUs). The weighted average sale price was $50.4865 per share, with individual trades executed between $49.09 and $52.00. After this tax-related sale, the officer beneficially owned 428,201 shares of IonQ common stock. The filing also notes that a prior RSU award reported in an earlier filing was adjusted to vest over three years, with a portion having vested on December 10, 2025 and the remaining units vesting in equal quarterly installments, subject to continued service.
IonQ, Inc. director reported an option exercise and share sale in the company’s stock. On 12/11/2025, the director exercised a stock option to acquire 20,000 shares of common stock at an exercise price of $4.61 per share. On the same day, the director sold 20,000 shares of common stock at a weighted average price of $51.399 per share under transaction code “S.” These trades were carried out pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025. Following the transactions, the director directly owned 60,839 shares of IonQ common stock and held 24,900 stock options, which are part of an option grant originally for 63,900 shares that vests in three equal annual installments starting July 11, 2023.
IonQ Inc. filed a notice of proposed insider stock sales under Rule 144. The filing covers the planned sale of 20,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $1,033,400. These shares were acquired on 12/11/2025 through the cash exercise of stock options granted by the issuer. The filing also notes that total common shares outstanding are 354,279,591, providing context for the size of the planned sale.
IonQ, Inc. insider plans additional share sale under Rule 144. A holder has filed a notice to sell 73,155 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of approximately $3,772,120.53. IonQ had 354,279,591 common shares outstanding. The shares to be sold were acquired on 12/11/2025 by exercising options under a registered plan and paid for in cash on the same date.
Over the past three months, the same seller and related joint accounts have already sold several IonQ common stock blocks, including 133,615 shares on 12/09/2025 for $7,181,124.81, 100,000 shares on 11/20/2025 for $4,686,054.00, and additional smaller sales. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about IonQ’s operations.
IonQ, Inc. insider plans sale of common stock under Rule 144. A person associated with IonQ has filed a notice to sell 4,490 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025 and an aggregate market value of 236,578. The filing notes that IonQ had 354,279,591 shares of common stock outstanding.
The 4,490 shares to be sold were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer. The notice also discloses that the same seller, identified as Paul Dacier at IonQ’s address, sold 4,175 shares of common stock on 09/11/2025 for gross proceeds of 185,376.68. By signing, the seller represents they are not aware of undisclosed material adverse information about IonQ.
IonQ filed a notice of planned stock sales under Rule 144. The filing covers the proposed sale of 15,420 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an aggregate market value of 812,480. The shares are part of a much larger base of 354,279,591 shares outstanding. These shares were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer, with the sale expected around 12/11/2025.